Expression and functional characterization of INPP4B in gallbladder cancer patients and gallbladder cancer cells

Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome

(2019) Peter Hammarsten et al.   MODERN PATHOLOGY

INPP4B inhibits cell proliferation, invasion and chemoresistance in human hepatocellular carcinoma

(2019) Wendong Tang et al.   OncoTargets and Therapy

INPP4B exerts a dual function in the stemness of colorectal cancer stem-like cells through regulating Sox2 and Nanog expression

(2019) Liwen Yang et al.   CARCINOGENESIS

INPP4B As A Prognostic And Diagnostic Marker Regulates Cell Growth Of Pancreatic Cancer Via Activating AKT

(2019) Shuyu Zhai et al.   OncoTargets and Therapy

INPP4B restrains cell proliferation and metastasis via regulation of the PI3K/AKT/SGK pathway

(2018) Ying Chen et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia

(2018) Hongjun Jin et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Overexpression of PEAK1 contributes to epithelial–mesenchymal transition and tumor metastasis in lung cancer through modulating ERK1/2 and JAK2 signaling

(2018) Chenbo Ding et al.   Cell Death & Disease

Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development

(2017) Hua-fu Zhao et al.   Molecular Cancer

Cell Proliferation and Cytotoxicity Assays

(2016) Aysun Adan et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer

(2016) Chenbo Ding et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer

(2016) Youliang Wu et al.   Oncotarget

INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia

(2015) I Dzneladze et al.   LEUKEMIA

The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses

(2015) Lifang Zhang et al.   Molecular Cancer

INPP4B is an oncogenic regulator in human colon cancer

(2015) S T Guo et al.   ONCOGENE

INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas

(2015) Meng Na Chi et al.   Oncotarget

PI3K/AKT signaling pathway and cancer: an updated review

(2014) Miriam Martini et al.   ANNALS OF MEDICINE

Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV

(2014) Yantao Duan et al.   Molecular Cancer

PI3K and cancer: lessons, challenges and opportunities

(2014) David A. Fruman et al.   NATURE REVIEWS DRUG DISCOVERY

INPP4B is highly expressed in prostate intermediate cells and its loss of expression in prostate carcinoma predicts for recurrence and poor long term survival

(2014) Natalie K. Rynkiewicz et al.   PROSTATE

Gallbladder Cancer

(2014) Jessica A. Wernberg et al.   SURGICAL CLINICS OF NORTH AMERICA

A Tumor Suppressor Function for the Lipid Phosphatase INPP4B in Melanocytic Neoplasms

(2013) Rolando Perez-Lorenzo et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Decreased Expression and Androgen Regulation of the Tumor Suppressor Gene INPP4B in Prostate Cancer

(2011) Myles C. Hodgson et al.   CANCER RESEARCH

Cancerous inhibitor of protein phosphatase 2A is overexpressed in cervical cancer and upregulated by human papillomavirus 16 E7 oncoprotein

(2011) Juan Liu et al.   GYNECOLOGIC ONCOLOGY

Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers

(2010) C. G. Fedele et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Evidence that Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor that Inhibits PI3K Signaling

(2009) Christina Gewinner et al.   CANCER CELL

Targeting the phosphoinositide 3-kinase pathway in cancer

(2009) Pixu Liu et al.   NATURE REVIEWS DRUG DISCOVERY